C011 Face Off: Evidence-Based Debates on Today’s Hottest Injectable Controversies
DESCRIPTION
As the field of injectables rapidly evolves, new techniques, products, and data enter the space. The dizzying amount of information available in the literature and social media often makes it difficult to discern hype from reality. This session brings together leading experts in the field to debate some of the hottest injectable controversies from an evidence-based perspective, helping attendees choose the most appropriate treatments and achieve natural-looking outcomes while maximizing patient safety. This course is intended for intermediate to advanced injectors.
LEARNING OBJECTIVES
Critically evaluate recent developments and controversies in injectable filler safety and efficacy to enhance patient selection and treatment planning.
Analyze advanced injection techniques and their associated risks to optimize outcomes, minimize complications, and achieve natural-looking results.
Examine emerging trends such as biostimulatory agents and combination therapies to develop a nuanced understanding of current debates, improving patient counseling on realistic expectations and individualized treatment outcomes.
DIRECTOR
Vince Bertucci, MD, FAAD
CO-DIRECTOR
Melanie Palm, MD, FAAD
SPEAKERS
Rohit Kakar, MD, FAAD
Rebecca A. Kazin, MD, FAAD
Marina Landau, MD, IFAAD
Jennifer Salsberg, MD, FAAD
DISCLOSURES
Vince Bertucci, MD, FAAD
Allergan, Inc – Consultant (1099 relationship)(Fees); Allergan, Inc. – Advisory Board(Fees), Investigator(Fees), Speaker(Honoraria); AMNI Aesthetic Medicine Network Inc. – Consultant(Honoraria); Caliway Biopharmaceuticals Co., Ltd – Investigator(Fees); Clarion Medical Technologies – Speaker(Honoraria); Evolus, Inc. – Advisory Board(Fees), Speaker(Honoraria); Galderma Canada, Inc – Speaker(Honoraria); Galderma Laboratories, L.P. – Advisory Board(Fees); Galderma USA – Investigator(Fees); Hydrafacial – Advisory Board(Fees); L'Oreal – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Medscape – Speaker/Faculty Education(Fees); Revance Therapeutics, Inc. – Advisory Board(Fees);
Rohit Kakar, MD, FAAD
No financial relationships exist with ineligible companies.
Rebecca A. Kazin, MD, FAAD
Allergan, Inc – Investigator(Grants/Research Funding), Stockholder(Stock); Galderma USA – Investigator(Grants/Research Funding), Speaker(Honoraria); Novaestiq Corp – Stockholder Private Company(Stock);
Marina Landau, MD, IFAAD
No financial relationships exist with ineligible companies.
Melanie Palm, MD, FAAD
Alastin Skincare, Inc – Investigator(Grants/Research Funding); Allergan, Inc – Advisory Board(Honoraria); BTL Industries – Speaker/Faculty Education(Honoraria); elta md – Advisory Board(Fees); Galderma Laboratories, L.P. – Consultant(Honoraria); L'Oreal USA Inc. – Investigator(Honoraria); Lumenis – Speaker(Honoraria); Merz Aesthetics – Speaker/Faculty Education(Honoraria); Revision Skincare – Investigator(Grants/Research Funding);
Jennifer Salsberg, MD, FAAD
No financial relationships exist with ineligible companies.